.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Johnson and Johnson
Citi
Chinese Patent Office
Express Scripts
Merck
Julphar
Fish and Richardson
Cerilliant
Chubb

Generated: June 23, 2017

DrugPatentWatch Database Preview

Enflurane - Generic Drug Details

« Back to Dashboard

What are the generic sources for enflurane and what is the scope of enflurane patent protection?

Enflurane
is the generic ingredient in two branded drugs marketed by Abbott, Baxter Hlthcare, and Piramal Critical, and is included in three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for enflurane.

Summary for Generic Name: enflurane

Tradenames:2
Patents:1
Applicants:3
NDAs:3
Drug Master File Entries: see list3
Bulk Api Vendors: see list35
Clinical Trials: see list3
Patent Applications: see list1,218
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:enflurane at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott
ENFLURANE
enflurane
LIQUID;INHALATION070803-001Sep 8, 1987DISCNNoNo► Subscribe► Subscribe
Piramal Critical
ENFLURANE
enflurane
LIQUID;INHALATION074396-001Jul 29, 1994DISCNNoNo► Subscribe► Subscribe
Baxter Hlthcare
ETHRANE
enflurane
LIQUID;INHALATION017087-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: enflurane

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare
ETHRANE
enflurane
LIQUID;INHALATION017087-001Approved Prior to Jan 1, 19823,469,011► Subscribe
Baxter Hlthcare
ETHRANE
enflurane
LIQUID;INHALATION017087-001Approved Prior to Jan 1, 19823,527,813► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Johnson and Johnson
UBS
Merck
Mallinckrodt
Teva
Moodys
Chubb
Boehringer Ingelheim
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot